Rhea Nadkarni

Rhea Nadkarni

Auto-generated profile, based on publicly available information

Rhea Nadkarni

Duke-NUS Medical School, Program in Cardiovascular and Metabolic Disorders, Singapore, Singapore 1

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RNRhea Nadkarni
Rhea Nadkarni
WCWern Cui Chu
Wern Cui Chu
CLCheryl Q.E. Lee
Cheryl Q.E. Lee
Yasir MohamudYasir Mohamud
Yasir Mohamud
LYLynn Yap
Lynn Yap
LHLena Ho
Lena Ho
Nucleotide-binding oligomerization domain (NBD), leucine-rich repeat (LRR) containing protein family (NLRs) are intracellular pattern recognition receptors that mediate innate immunity against infections. The endothelium is the first line of defense against blood-borne pathogens, but it is unclear which NLRs control endothelial cell (EC) intrinsic immunity. Here, we demonstrate that human ECs simultaneously activate NLRP1 and CARD8 inflammasomes in response to DPP8/9 inhibitor Val-boro-Pro (VbP). Enterovirus Coxsackie virus B3 (CVB3)—the most common cause of viral myocarditis—predominantly activates CARD8 in ECs in a manner that requires viral 2A and 3C protease cleavage at CARD8 p.G38 and proteasome function. Genetic deletion of CARD8 in ECs and human embryonic stem cell–derived cardiomyocytes (HCMs) attenuates CVB3-induced pyroptosis, inflammation, and viral propagation. Furthermore, using a stratified endothelial–cardiomyocyte co-culture system, we demonstrate that deleting CARD8 in ECs reduces CVB3 infection of the underlying cardiomyocytes. Our study uncovers the unique role of CARD8 inflammasome in endothelium-intrinsic anti-viral immunity.